Stocktwits Top 25 – Week 33 📉

Good afternoon everyone and welcome to the Stocktwits Top 25 Newsletter for Week 33, 2020. 

The Stocktwits Top 25 reports the top 25 performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date (YTD) and tracks their performances over time. 

Here’s your Stocktwits Top 25 Lists for Week 33:

ST Top 25 S&P 500

15 out of the 25 names on the ST Top 25 S&P 500 list closed lower on the week. For reference, 18 of the 25 names closed higher last week.

Apple was the list’s biggest winner up 3.27%. It has closed green 17 out of the last 21 weeks since its March low and its market cap is this close 👌🏼 from $2 Trillion. 😳

Newmont Corporation was the biggest loser, falling 7.34% and 7 spots from #13 to #20. See more on this below.

Chipotle Mexican Grill was cooking (relatively). It gained 0.50% and claimed the #25 spot as the only Freshman on the list.

Carrier Global continues its tremendous run since its IPO up another 2% and now up 122% YTD.

The Stocktwits Top 25 S&P 500 Momentum Meter closed down 0.66%. It wasn’t enough to beat the full index which closed higher by 0.64%. The differential of 1.3% indicates that the top stocks in the S&P 500 lagged the full Index.

The Big Cap Nasdaq 100

The Stocktwits Top 25 Nasdaq 100 was a sea of red during week #33. 5 of the top 8 names dropped more than 3% and 17 outta 25 closed lower.  

Zoom led the pack of losers, falling 5.31%. It’s still up 260% YTD.

Tesla was the sharpest tool in the shed gaining 13.63% on news of a 5 for 1 stock split. We’ll circle back below.

Similar to $CMG on the S&P 500 list, Adobe was the only Freshman on the N100 list. It dropped .5% on the week, but still managed to enter the list at #25.

The ST Top 25 Nasdaq 100 Momentum Meter lost 0.39% for week #33 while the full Nasdaq 100 gained 0.13%. The -0.52% differential suggests the top stocks underperformed the full index by a bit. 

Small-Cap Russell 2000

Volatility in the ST Top 25 R2K list returned once again. 13 stocks closed plus or minus 10% or more for the week. 17 of 25 stocks closed lower. 

Novavax remained in the top spot despite falling 14% this week. Vaxart trails in 2nd place by over 1,000%! 

Seres Therapeutics was the leading Freshman with a 488% weekly gain! 💪 It claimed the #8 spot. See what spurred on the massive gain below.

Overshadowed by Seres, $APPS was the other Freshman gaining 9.52%. It entered the list at #23.

$CODX and $IBIO, both biotechs, fell 36% and 31% this week. You can read about them in the Sinners Section below.

The ST Top 25 R2K List’s Momentum Meter scaled 13.21% higher while the full Russell 2000 rose 0.55%. While the 12.66% differential implies the top stocks outperformed the full index by a country mile, the full difference and then some is attributable to the huge gain in Seres ($MCRB).


The ST Top 25 Top Dawg of the Week for Week 33, 2020 is Seres Therapeutics.

The biotech is a Freshman on the ST Top 25 R2K List and now ranked at #8. It takes most stocks weeks, if not months to climb the list and grab a top ten spot. It took this stock a single week to jump to the top ten. Damn impressive. 👏

$MCRB opened the week exploding higher on positive results from a Phase 3 test on its SER-109 oral drug. On Monday, the stock soared as high as +609% intraday before closing up 389%. The drug treats a fatal colon infection called “C. Difficile Infection” or “CDI”. 

The Phase 3 study reported “a highly statistically significant absolute decrease of 30.2% in the proportion of patients who experienced a recurrence in CDI within eight weeks of administration versus placebo.”

Dr. Lisa von Motlke of Seres had this to say, 

Novel microbiome therapeutic candidate could potentially provide a much-needed effective oral treatment option for the approximately 170,000 patients in the U.S. that suffer from recurrent CDI annually,

$MCRB flew another 21.31% on Thursday after the company announced a 10.5 million share offering

Valiant efforts by the team at Seres. We applaud you and wish only the best.

Here’s the killer intraday chart of Seres jumping on the announcements.

The Winners 📈

△  #10 R2K – Inc looks like a fresh 68’ Camaro. It closed up 18.71% and gained 1 spot on the ST Top 25 R2K List. True Americana. 

The stock raced ahead 12% on Monday ahead of its after-hours earnings report. The earnings report kicked a$$ on both top and bottom lines. 

Here are the numbers:

EPS: $0.03 vs ($0.01) est.
Revenue: $118.9M vs $64.9M est.

Here’s a money statement from CEO Lev Peker:

This quarter marked another period of significant growth for our company as we reported record-breaking sales and gross profit. In addition to our strong top-line momentum, we drove exceptional year-over-year bottom-line improvements in both net income and Adjusted EBITDA. Despite the ongoing pandemic and an uncertain market environment, our accelerated momentum points to the continued success of our strategy and resilience of our business. Overall e-commerce penetration for total U.S. retail sales reached 28% for Q2 while auto parts remains in the mid-single digits. We believe that the industry will continue to experience the shift to online and we are well-positioned to take advantage of this new demand over the long term. 

$PRTS is up 560.45% YTD. What a ride 2020 has been.

△ #1 N100 – Tesla Inc resumed its uptrend this week after trading quietly in late July/early August. Elon’s stock trekked 13.63% higher on above-average volume solidifying the top  spot on the ST Top 25 N100 List.

And if you didn’t hear, $TSLA announced a 5 for 1 stock split on Tuesday after the close. This followed Apple’s 4 for 1 split two weeks back.

Stock splits allow for smaller investors to accumulate and trade as the share price isn’t so expensive. Here’s Nasdaq’s Chief Economist Phil Mackintosh on why splits make sense for expensive share priced companies.

The YTD chart is a spectacle, up 294.6%.

The Sinners 📉

▼ #1 R2K – Novavax Inc. The #1 ranked stock on the ST Top 25 R2K List fell 14% this week. This comes after the stock was up 19% in Week #32. 

$NVAX reported earnings after Monday’s close, here are the numbers:

EPS: ($0.30) vs ($0.51) est.
Revenue: $35.5M

Despite the better than expected earnings, the company missed the mark on sales.

Here’s the YTD daily chart.

$NVAX is up 3,579% YTD.

▼ #20 S&P 500 – Newmont Corporation lost momentum and got knocked 7.34% this week. It fell 7 spots from #13 to #20 on the ST Top 25 S&P 500 List. This comes after the stock closed at all-time highs in Week #32.

$NEM opened 5% lower Tuesday and continued to fall closing down 7.39%. The stock tumbled as Gold also got hit dropping 5.72% last Tuesday.

Here’s a cool stat, the SPDR Gold Shares also saw its biggest outflow of $382 million on Friday, August 7th.

▼ #3 R2K – Co Diagnostics Inc got taken out to the slaughterhouse. The biotech kicked off the week losing 6% Monday, tumbled another 15.83% Wednesday, and followed suit Friday selling off 22%. It’s seen better days. 

On Thursday, $CODX missed estimates on both top and bottom line. Wall Street expected earnings of $0.59 per share on revenue of $26.5 million. The company reported earnings of $0.46 per share on revenue of $24 million. 

$CODX hit an all-time high on August 3rd, but it’s now down 47% since then. Is this a bear market??? 

▼ #7 R2K – Ibio Inc makes yet another appearance. The name was highlighted on this same list 1 week ago after it lost 14.41%. This week it dropped more than twice as much, falling 31.58%. It lost 2 spots sliding from #5 to #7 on the ST Top 25 R2K list.

$IBIO plunged 21% after Russia announced its coronavirus vaccine on Tuesday. Fellow sinner $NVAX, and prior sinner $INO, dropped 16% and 23% the same day. 

Here’s the intraday chart displaying this week’s fragility:

See Y’all Next Week.